-
The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams.
Please read these conditions carefully before using this site. By using this site, you signify your assent to the following terms and conditions of use without limitation or qualification. In particular, you consent to the use of all cookies on this website for the purposes described in the terms of use. If you do not agree to these terms or to the use of cookies as described below, do not use this site. AllianceBernstein may at any time revise these terms of use. You are bound by any such revisions and should therefore periodically visit this page to review the then current terms of use to which you are bound. This site is for informational purposes and does not constitute an offer to sell or a solicitation of an offer to buy any security which may be referenced herein.
This site is solely intended for use by professional/institutional investors and institutional-investment industry consultants.
Do you wish to continue?
Attractive valuations—Even after a stellar 2017, EM stocks trade at 12.5 times estimated earnings for the next 12 months—a 27% discount to developed-market (DM) stocks. That’s only slightly higher than at the end of 2016, when EM stocks traded at 11.9 times estimated earnings for the next 12 months.
Through December 31, 2017
Source: FactSet, MSCI and AllianceBernstein
Catch-up just beginning—EM companies had several tough years, with subdued earnings, low profitability and depressed valuations. There’s plenty of room to catch up with DM peers. And in the past, EM equity cycles persisted for several years. Between 2002 and 2007, the MSCI Emerging Markets returned an annualized 28.6%.
Sources of returns—This year’s performance has been driven mostly by earnings growth—not multiple expansion. This indicates that there’s still plenty of pent-up return potential in EM equities.
Broadening recovery—Chinese and technology stocks have driven the rebound in 2017. We think the rally could broaden to more sectors and regions as earnings growth continues and confidence grows.
Easing China risks—Positive signs are surfacing in China, including firming producer price index inflation and improving profitability of commodity producers and industrial companies. We think these trends reduce the risks to the banking system. And a stronger China outlook may help foster confidence in EM stocks more broadly—and could lead investors to focus more on company fundamentals.
The views expressed herein do not constitute research, investment advice or trade recommendations and do not necessarily represent the views of all AB portfolio-management teams.
Sammy Suzuki is Head of Emerging Markets Equities, responsible for overseeing AB’s emerging-markets equity business and instrumental in the formation and shaping of AB’s Emerging Markets Equity platform. He was also a key architect of the Strategic Core platform and has managed the Emerging Markets Portfolio since its inception in 2012, and the Global, International and US portfolios from 2015 to 2023. Suzuki has managed portfolios since 2004. From 2010 to 2012, he also held the role of director of Fundamental Value Research, where he managed 50 fundamental analysts globally. Prior to managing portfolios, Suzuki spent a decade as a research analyst. He joined AB in 1994 as a research associate, first covering the capital equipment industry, followed by the technology and global automotive industries. Before joining the firm, Suzuki was a consultant at Bain & Company. He holds both a BSE (magna cum laude) in materials engineering from the School of Engineering and Applied Science, and a BS (magna cum laude) in finance from the Wharton School at the University of Pennsylvania. Suzuki is a CFA charterholder and was previously a member of the Board of the CFA Society New York. He currently serves on the Board of the Association of Asian American Investment Managers. Location: New York